TB-500 dosage is one of the most searched questions about this peptide, and the research answer is short: there isn’t a validated one. TB-500 has never been through a completed human clinical trial. This page explains what the research actually studied, why figures shared online are not research-backed, and how TB-500 is handled accurately in a lab setting.

For laboratory research use only. Not for human or veterinary use. Nothing on this page is usage guidance or medical advice.

Key takeaways

What Is TB-500?

TB-500 is the research name for a synthetic fragment related to thymosin beta-4, a naturally occurring protein involved in cell movement and tissue repair. It is supplied as a freeze-dried powder for laboratory research. For the wider background, see the TB-500 peptide overview.

Why There’s No Established TB-500 Dosage

An amount becomes “established” only after controlled human trials test safety and effect at specific amounts. TB-500 has not had those trials. That leaves three gaps:

So any schedule shared online is community practice, not a research finding. Project Amino does not publish or endorse those figures.

What the Research Does Show

The underlying peptide, thymosin beta-4, has a genuine research base. A review of thymosin beta-4’s tissue-repair properties describes its roles in cell migration, blood-vessel formation and wound healing, mostly in animal and lab models. The human studies that do exist focus on full-length thymosin beta-4 in topical and eye formulations — not on TB-500 fragments.

Question What research shows
Is there a human TB-500 trial? No
Is there animal research? Yes, mainly on thymosin beta-4 and tissue repair
Is there human data on thymosin beta-4? Limited — topical and eye formulations
Is there a validated human amount? No

Accurate Lab Handling

Research is only repeatable when the material is handled accurately. For TB-500 that means:

TB-500 and BPC-157 in Research

TB-500 is often studied alongside BPC-157, since both appear in tissue-repair research. Their reported effects in animal models are frequently compared. The BPC-157 and TB-500 reference covers handling the combination, and the BPC-157 research guide is the starting point for the full library.

Frequently Asked Questions

What is the TB-500 dosage?

There is no validated TB-500 dosage. Without a completed human clinical trial, no amount has been established as safe or effective. Figures shared online come from community sources, not published research.

Is there human trial data for TB-500?

No. The strongest human evidence is for full-length thymosin beta-4 in topical and eye formulations, not research-grade TB-500.

What has TB-500 been studied for?

Research on the related peptide thymosin beta-4 focuses on tissue repair, cell migration and wound healing, mostly in animal and lab models.

Is TB-500 FDA-approved?

No. TB-500 is not approved by the FDA for any use. It is sold for laboratory research only and is prohibited in competitive sport by WADA.

How is TB-500 measured in the lab?

After reconstitution, TB-500 is measured by volume against the concentration set during mixing. This is lab math, not usage guidance.

Research-Grade Material

Project Amino supplies BPC-157 + TB-500 synthesized in the US and third-party lab tested, with a certificate of analysis available per batch.

Important Regulatory Notice

TB-500 sold by Project Amino is a research chemical for laboratory and research use only. It is not a drug, supplement or medical product, and it is not approved by the FDA. It is not intended for human or veterinary use, or for the diagnosis, treatment, cure or prevention of any disease. All statements describe published research and are for educational purposes only. Purchasers must be 21 or older and are responsible for compliant handling.

🎉 Thank you for your order!

Love our products?

Love our products? Join our Affiliate Program and earn 20% commission every time someone purchases through your referral link.

Customer Reviews